Table 2.

Logistic regression model evaluating relation of laboratory parameters with more than 1 type of acute complication

ORaOR
>1 type of acute complication OR95% CIPOR95% CIP
Pediatric cohort 
PoS (10 mmHg ↑) 1.75 1.23-2.49 .002  1.65 1.16-2.35 .006  
EImin (0.1 EI ↑) 0.45 0.30-0.68 <.0001  0.50 0.33-0.76 .001  
EImax (0.1 EI ↑) 0.64 0.45-0.92 .014  0.70 0.49-1.00 .052 
Blood viscosity (1.0 cP ↑)  1.18 0.81-1.71 .400 1.06 0.71-1.58 .770 
HVR 0.77 0.48-1.24 .285 0.88 0.54-1.43 .598 
Hb (1.0 g/dL ↑) 1.04 0.83-1.30 .752 1.02 0.81-1.29 .859 
HbF (10.0% ↑)§  0.55 0.31-0.97 .039 0.76 0.40-1.44 .396 
MCV (10 fl ↑) 1.16 0.90-1.50 .240 1.04 0.81-1.34 .744 
MCHC (1.0 g/dL ↑) 1.03 0.80-1.31 .836 1.06 0.82-1.38 .643 
MCH (10.0 pg ↑) 0.94 0.45-1.98 .868 0.71 0.32-1.56 .395 
ARC (100 ×109/L ↑) 1.35 1.09-1.67 .005  1.34 1.07-1.67 .011  
Dense RBCs (1.0% ↑) 1.15 1.04-1.26 .006  1.10 0.99-1.22 .071 
Adult cohort 
PoS (10 mmHg ↑) 2.46 1.26-4.79 .009 3.00 1.32-6.83 .015 
EImin (0.1 EI ↑) 0.41 0.16-1.02 .053 0.39 0.13-1.14 .085 
EImax (0.1 EI ↑) 0.38 0.17-0.98 .016 0.33 0.12-0.92 .035 
Blood viscosity (1.0 cP ↑) n/a n/a n/a n/a n/a n/a 
HVR n/a n/a n/a n/a n/a n/a 
Hb (1.0 g/dL ↑) 0.91 0.55-1.48 .692 0.91 0.55-1.49 .706 
HbF (10.0% ↑) 0.51 0.24-1.08 .077 0.49 0.19-1.28 .149 
MCV (10 fl ↑) 1.02 0.71-1.48 .918 1.27 0.78-2.08 .334 
MCHC (1.0 g/dL ↑) 1.16 0.73-1.83 .539 1.19 0.74-1.89 .478 
MCH (10.0 pg ↑) 1.03 0.94-1.13 .517 1.08 0.96-1.22 .183 
ARC (100 ×109/L ↑) 1.04 0.97-1.11 .252 1.03 0.95-1.11 .440 
Dense RBCs (1.0% ↑) n/a n/a n/a n/a n/a n/a 
ORaOR
>1 type of acute complication OR95% CIPOR95% CIP
Pediatric cohort 
PoS (10 mmHg ↑) 1.75 1.23-2.49 .002  1.65 1.16-2.35 .006  
EImin (0.1 EI ↑) 0.45 0.30-0.68 <.0001  0.50 0.33-0.76 .001  
EImax (0.1 EI ↑) 0.64 0.45-0.92 .014  0.70 0.49-1.00 .052 
Blood viscosity (1.0 cP ↑)  1.18 0.81-1.71 .400 1.06 0.71-1.58 .770 
HVR 0.77 0.48-1.24 .285 0.88 0.54-1.43 .598 
Hb (1.0 g/dL ↑) 1.04 0.83-1.30 .752 1.02 0.81-1.29 .859 
HbF (10.0% ↑)§  0.55 0.31-0.97 .039 0.76 0.40-1.44 .396 
MCV (10 fl ↑) 1.16 0.90-1.50 .240 1.04 0.81-1.34 .744 
MCHC (1.0 g/dL ↑) 1.03 0.80-1.31 .836 1.06 0.82-1.38 .643 
MCH (10.0 pg ↑) 0.94 0.45-1.98 .868 0.71 0.32-1.56 .395 
ARC (100 ×109/L ↑) 1.35 1.09-1.67 .005  1.34 1.07-1.67 .011  
Dense RBCs (1.0% ↑) 1.15 1.04-1.26 .006  1.10 0.99-1.22 .071 
Adult cohort 
PoS (10 mmHg ↑) 2.46 1.26-4.79 .009 3.00 1.32-6.83 .015 
EImin (0.1 EI ↑) 0.41 0.16-1.02 .053 0.39 0.13-1.14 .085 
EImax (0.1 EI ↑) 0.38 0.17-0.98 .016 0.33 0.12-0.92 .035 
Blood viscosity (1.0 cP ↑) n/a n/a n/a n/a n/a n/a 
HVR n/a n/a n/a n/a n/a n/a 
Hb (1.0 g/dL ↑) 0.91 0.55-1.48 .692 0.91 0.55-1.49 .706 
HbF (10.0% ↑) 0.51 0.24-1.08 .077 0.49 0.19-1.28 .149 
MCV (10 fl ↑) 1.02 0.71-1.48 .918 1.27 0.78-2.08 .334 
MCHC (1.0 g/dL ↑) 1.16 0.73-1.83 .539 1.19 0.74-1.89 .478 
MCH (10.0 pg ↑) 1.03 0.94-1.13 .517 1.08 0.96-1.22 .183 
ARC (100 ×109/L ↑) 1.04 0.97-1.11 .252 1.03 0.95-1.11 .440 
Dense RBCs (1.0% ↑) n/a n/a n/a n/a n/a n/a 

A logistic regression analysis was performed to calculate ORs for oxygen gradient ektacytometry–derived parameters, blood viscosity, DRBCs, HbF, and hemocytometry parameters in relation to occurrence of >1 type of acute complication.

aORs were corrected for age and hydroxyurea therapy.

CI, confidence interval; cP, centipoize; HVR, hematocrit to viscosity ratio; MCHC, mean corpuscular Hb concentration; MCH, mean corpuscular Hb.

ACS, VOEs, and/or cerebral infarction.

OR is significant after correcting for multiple testing (False discovery rate analysis).

Data of 110 individuals available.

§

Data of 90 individuals available.

Close Modal

or Create an Account

Close Modal
Close Modal